Table 2.
Three-year overall and relapse-free survival rates, and one-year survival after relapse rates in MSS/left and MSS/right populations, stratified by mutation status
| |
MSS/left |
MSS/right |
||
|---|---|---|---|---|
| Population | Survival rate | 95% CI | Survival rate | 95% CI |
| OS: 3-year survival rates | ||||
| WT2 |
0.91 |
0.88-0.93 |
0.83 |
0.77-0.89 |
| KRAS mut |
0.89 |
0.85-0.93 |
0.80 |
0.74-0.86 |
| BRAF mut |
0.37 |
0.20-0.66 |
0.73 |
0.60-0.89 |
| RFS: 3-year survival rates | ||||
| WT2 |
0.75 |
0.71-0.80 |
0.75 |
0.68-0.82 |
| KRAS mut |
0.68 |
0.62-0.74 |
0.73 |
0.66-0.80 |
| BRAF mut |
0.32 |
0.16-0.61 |
0.68 |
0.54-0.84 |
| SAR: 1-year survival rates | ||||
| WT2 |
0.81 |
0.74-0.88 |
0.65 |
0.52-0.82 |
| KRAS mut |
0.80 |
0.71-0.89 |
0.75 |
0.53-0.80 |
| BRAF mut | 0.17 | 0.05-0.60 | 0.36 | 0.17-0.79 |